New cough combo drug tested in healthy people for first time
NCT ID NCT07161180
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early-phase trial is testing a new combination drug called PBK_M2301, which contains two ingredients: levodropropizine (a cough suppressant) and Pelargonium sidoides extract (a herbal remedy). The study involves 32 healthy adults aged 19 to 64. Each person will take the combination drug and the two ingredients separately at different times, with a week break in between. The goal is to measure how the drug moves through the body and check for any safety issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PBK_M2301 (a tablet combining levodropropizine and Pelargonium sidoides extract)
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H+ Yangji Hospital
RECRUITINGSeoul, Seoul, 08799, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••